NCT01557517View on ClinicalTrials.gov

Clobetasol for Oral Graft-Versus-Host Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

March 28, 2012

Primary Completion Date

June 9, 2017

Study Completion Date

August 24, 2017

Conditions
Oral Chronic Graft vs Host Disease
Interventions
DRUG

Clobetasol Oral Rinse

Cycle= up to 4 weeks Patients will rinse oral cavity with 10cc of clobetasol 0.05% oral rinse for 2 minutes 3 times a day.

DRUG

Placebo oral rinse

Patients will rinse oral cavity with 10cc of placebo oral rinse for 2 minutes 3 times a day.

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT01557517 - Clobetasol for Oral Graft-Versus-Host Disease | Biotech Hunter | Biotech Hunter